ardiovascular diseases like coronary artery disease and cerebrovascular disease are consistently among the leading causes of global mortality. These diseases not only result in a significant loss of life but also impose a substantial burden on healthcare systems. Similarly, endocrine and metabolic disorders, such as diabetes and thyroid disorders, affect a vast number of people globally, directly impacting their quality of life and contributing to significant health and economic burdens. Immunoinflammatory diseases, including asthma and autoimmune disorders, are on the rise, likely due to environmental changes and lifestyle modifications.
This research project focuses on understanding three major categories of diseases: cardiovascular diseases, endocrine and metabolic disorders, and immunoinflammatory diseases. These conditions have a profound impact on global health and can significantly affect an individual’s quality of life. We will conduct our investigation using the extensive dataset provided by the UK Biobank.
Our primary goal is to explore these diseases comprehensively. We intend to delve into their clinical aspects, genetic factors, potential risk factors, treatment effectiveness, and patient outcomes. To achieve this, we will establish patient cohorts related to cardiovascular and metabolic diseases. Our specific objectives include: examining how these diseases may be interconnected, evaluating the effectiveness and safety of medications used in treating these conditions, investigating the genetic characteristics related to these diseases, determining potential factors that may contribute to the development of these diseases, following up on patient outcomes based on different interventions.
We will utilize data from the UK Biobank, which includes various information such as demographic details, questionnaire responses, laboratory test results, genetic data, and linked health-related records. With this data, we will establish patient cohorts for each disease category and compile relevant variables from different databases.
We anticipate that this research will provide valuable insights into the clinical, genetic, and pharmacological aspects of cardiovascular diseases, endocrine and metabolic disorders, and immunoinflammatory diseases. These findings will not only enhance our understanding of these conditions but also have practical implications.
